<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00709241</url>
  </required_header>
  <id_info>
    <org_study_id>P051044</org_study_id>
    <nct_id>NCT00709241</nct_id>
  </id_info>
  <brief_title>Psychosocial Patterns and Prognosis in Patients With Heart Failure</brief_title>
  <acronym>PANIC</acronym>
  <official_title>Prognostic Value of Negative Affectivity in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective observational study is designed to confirm the prognostic and economic&#xD;
      impact of depression in ambulatory patients with systolic or diastolic heart failure, to&#xD;
      explore the impact of other psychosocial patterns such as type D personality, anxiety&#xD;
      disorders, locus of control, perceived social support, anger, hopelessness, and to evaluate&#xD;
      potential pathophysiological and behavioral pathways.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies suggest that depressive symptoms may be associated with a worse prognosis and higher&#xD;
      costs of care in patients with chronic heart failure in some populations, but such data in a&#xD;
      French population are missing. On the other hand, little is known of the impact of other&#xD;
      psychosocial dysfunction whereas the pathophysiology of this association remains&#xD;
      hypothetical.&#xD;
&#xD;
      Main objective: to confirm the impact of depressive symptoms on cardiovascular death in&#xD;
      ambulatory heart failure patients&#xD;
&#xD;
      Other objectives:&#xD;
&#xD;
        -  to study the impact of depressive symptoms on sudden death, non cardiovascular death,&#xD;
           and hospitalization rates;&#xD;
&#xD;
        -  to study the role of other psychosocial patterns or personality traits such as anxiety&#xD;
           disorders, locus of control, perceived social support, anger, hopelessness, optimism and&#xD;
           type D personality in cardiovascular and total mortality;&#xD;
&#xD;
        -  to study the interaction with patient behaviors (drug compliance, addictions);&#xD;
&#xD;
        -  to explore some pathophysiological pathways (chronic inflammation and chronic loss of&#xD;
           myocytes),&#xD;
&#xD;
        -  and to evaluate the impact of psychosocial distress on health care costs. Design:&#xD;
           multicenter observational study with a minimum of 2 year follow up Population: 700&#xD;
           ambulatory patients, aged above 18 y.o., with acute heart failure within the last 24&#xD;
           months&#xD;
&#xD;
      Methodology:&#xD;
&#xD;
        -  psychosocial patterns and personality traits are assessed using validated&#xD;
           self-administered questionnaire; use of the Beck Depression Index in this population is&#xD;
           validated against the Montgomery &amp; Asberg Depression Rating Scale evaluation&#xD;
&#xD;
        -  cardiac condition is evaluated at pre-defined time period by B-natriuretic peptide&#xD;
           levels, echocardiography and 6'-walk test&#xD;
&#xD;
      End-point criteria:&#xD;
&#xD;
        -  primary : rate of cardiovascular death&#xD;
&#xD;
        -  secondary : rate of total mortality and sudden death, rate of rehospitalization for&#xD;
           heart failure and for any cause, total and specific health care costs.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>total mortality, sudden death rate, non cardiovascular mortality, rate of hospitalization, of rehospitalization for heart failure, of hospitalization for cardiovascular and non cardiovascular reasons,total health care costs and nature of theses costs</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">325</enrollment>
  <condition>Systolic Heart Failure</condition>
  <condition>Diastolic Heart Failure</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum, urine.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        heart failure patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age above 18,&#xD;
&#xD;
          -  acute heart failure within the last 24 months&#xD;
&#xD;
          -  stable cardiovascular condition for at least 2 weeks&#xD;
&#xD;
          -  non hospitalized, non institutionalized patient,&#xD;
&#xD;
          -  french speaking and reading,&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non inclusion criteria :&#xD;
&#xD;
          -  curable cardiomyopathy, cardiomyopathies associated with systemic illnesses&#xD;
             (Lupus...), neurodegenerative or pulmonary illnesses, or hypertrophic/restrictive&#xD;
             cardiomyopathy&#xD;
&#xD;
          -  unstable cardiovascular condition&#xD;
&#xD;
          -  heart transplant and hemodialysis patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François LEDRU, MD PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Georges pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <study_first_submitted>July 2, 2008</study_first_submitted>
  <study_first_submitted_qc>July 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2008</study_first_posted>
  <last_update_submitted>October 22, 2014</last_update_submitted>
  <last_update_submitted_qc>October 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Psychosocial factors</keyword>
  <keyword>Depression</keyword>
  <keyword>Patient compliance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Diastolic</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

